CREBZF and breast carcinoma: To verify the therapeutic feasibility of CREBZF-mRNA-NPs in breast cancer xenograft model, we systemically injected CREBZF-mRNA-NPs through tail vein in nude mice bearing CREBZF-null MCF-7 xenograft tumors every three days for seven injections cycles.